1. Home
  2. LFVN vs RNTX Comparison

LFVN vs RNTX Comparison

Compare LFVN & RNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lifevantage Corporation (Delaware)

LFVN

Lifevantage Corporation (Delaware)

HOLD

Current Price

$6.24

Market Cap

78.0M

Sector

Health Care

ML Signal

HOLD

RNTX

Rein Therapeutics Inc.

HOLD

Current Price

$0.75

Market Cap

65.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LFVN
RNTX
Founded
N/A
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
78.0M
65.3M
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
LFVN
RNTX
Price
$6.24
$0.75
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
★ $11.00
$10.00
AVG Volume (30 Days)
46.4K
★ 354.9K
Earning Date
05-06-2026
05-15-2026
Dividend Yield
★ 3.56%
N/A
EPS Growth
N/A
★ 44.16
EPS
★ 0.40
N/A
Revenue
★ $203,204,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.73
★ N/A
Revenue Growth
★ 1.86
N/A
52 Week Low
$3.90
$0.69
52 Week High
$11.71
$2.18

Technical Indicators

Market Signals
Indicator
LFVN
RNTX
Relative Strength Index (RSI) 46.57 42.33
Support Level $6.12 $0.71
Resistance Level $6.78 $0.88
Average True Range (ATR) 0.30 0.06
MACD 0.01 -0.00
Stochastic Oscillator 33.77 13.94

Price Performance

Historical Comparison
LFVN
RNTX

About LFVN Lifevantage Corporation (Delaware)

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of in the United States, Mexico, Canada, Japan, Taiwan, Thailand, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, Austria, Spain, Ireland, Belgium, and Others. The company operates in a single operating segment by selling products directly to customers through an international network of independent consultants that operate in an integrated manner.

About RNTX Rein Therapeutics Inc.

Rein Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications with no approved or limited effective treatments. Its pipeline includes: LTI-03, a peptide, for placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis, that has demonstrated the ability to protect healthy lung epithelial cells and reduce pro-fibrotic signaling; LTI-01, a proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment.

Share on Social Networks: